Release date: July 4, 2017

Author: Chen weiwei

Source: Chinese Circulation Journal.2017;32(6):521-530

Abstract: The prevalence of cardiovascular risk factors in China is arising, which increased the number of patients with cardiovascular diseases. Overall, the morbidity and mortality of cardiovascular disease in China is still on the ascendant phase. By estimation, the number of patients with cardiovascular disease were 290 million, of which 13 million were stroke patients, 11 million were coronary heart disease patients, 4.5 million were heart failure patients, 5 million were pulmonary heart disease patients, 2.5 million were rheumatic heart disease patients, 2 million were congenital heart disease patients, 2.7 billion were high blood pressure disease patients. The mortality of cardiovascular disease ranked first, much higher than that of cancer or other diseases. It was accounting for more than 40% of resident deaths caused by diseases. In recent years, especially in rural areas, the mortality of cardiovascular disease continued to be higher than it in urban areas. Since 2004, the hospitalization cost of cardiovascular and cerebrovascular disease was also increasing rapidly. Its average annual growth rate is much higher than GDP growth rate. The increasing burden of cardiovascular disease in our country has become a major public health problem. The prevention and treatment for cardiovascular diseases are urgent.